Zürcher Nachrichten - Mice trial raises hopes for 'on demand' male contraceptive

EUR -
AED 4.049778
AFN 78.834299
ALL 99.033342
AMD 431.456343
ANG 1.973823
AOA 1005.540147
ARS 1184.510488
AUD 1.740106
AWG 1.984619
AZN 1.871047
BAM 1.951157
BBD 2.225918
BDT 133.95119
BGN 1.953417
BHD 0.415629
BIF 3226.660051
BMD 1.102566
BND 1.473074
BOB 7.618042
BRL 6.190801
BSD 1.102437
BTN 94.108603
BWP 15.256919
BYN 3.607729
BYR 21610.297969
BZD 2.214448
CAD 1.554541
CDF 3167.672699
CHF 0.949657
CLF 0.027281
CLP 1046.908381
CNY 8.028391
CNH 8.030442
COP 4581.504452
CRC 555.45727
CUC 1.102566
CUP 29.218005
CVE 110.006211
CZK 25.045922
DJF 195.947771
DKK 7.461959
DOP 69.623267
DZD 146.912551
EGP 55.769964
ERN 16.538493
ETB 145.130438
FJD 2.566609
FKP 0.849767
GBP 0.842206
GEL 3.042781
GGP 0.849767
GHS 17.089472
GIP 0.849767
GMD 78.830087
GNF 9541.515201
GTQ 8.509592
GYD 230.665979
HKD 8.575705
HNL 28.207398
HRK 7.54001
HTG 144.267713
HUF 403.661068
IDR 18465.889357
ILS 4.082247
IMP 0.849767
INR 94.030872
IQD 1444.233926
IRR 46431.844181
ISK 144.314781
JEP 0.849767
JMD 173.672773
JOD 0.781606
JPY 161.04578
KES 142.506807
KGS 95.60528
KHR 4409.646484
KMF 500.014042
KPW 992.369183
KRW 1600.661596
KWD 0.339262
KYD 0.918627
KZT 552.612033
LAK 23885.559894
LBP 98786.765454
LKR 327.39557
LRD 220.466371
LSL 20.781097
LTL 3.255591
LVL 0.666932
LYD 5.33219
MAD 10.487244
MDL 19.686991
MGA 5027.940557
MKD 61.511679
MMK 2314.787019
MNT 3851.769118
MOP 8.833576
MRU 43.813776
MUR 50.023376
MVR 16.990372
MWK 1911.842309
MXN 22.023316
MYR 4.897654
MZN 70.451818
NAD 20.780251
NGN 1695.23982
NIO 40.564638
NOK 11.404074
NPR 150.576289
NZD 1.901293
OMR 0.424466
PAB 1.102556
PEN 4.048086
PGK 4.549174
PHP 62.857624
PKR 309.248804
PLN 4.227851
PYG 8845.546281
QAR 4.019435
RON 4.978193
RSD 117.17297
RUB 92.685108
RWF 1572.964625
SAR 4.136492
SBD 9.180809
SCR 15.773594
SDG 662.092022
SEK 10.787111
SGD 1.473199
SHP 0.866444
SLE 25.171542
SLL 23120.263604
SOS 630.003648
SRD 40.298877
STD 22820.894741
SVC 9.647255
SYP 14336.339478
SZL 20.788701
THB 37.64133
TJS 12.001035
TMT 3.870007
TND 3.373498
TOP 2.582323
TRY 41.871279
TTD 7.474586
TWD 36.451059
TZS 2924.510568
UAH 45.517981
UGX 4017.56488
USD 1.102566
UYU 46.573677
UZS 14239.435486
VES 77.098718
VND 28451.721382
VUV 136.24344
WST 3.123386
XAF 654.272445
XAG 0.034516
XAU 0.000355
XCD 2.97974
XDR 0.825967
XOF 654.373081
XPF 119.331742
YER 270.845622
ZAR 20.688194
ZMK 9924.417531
ZMW 30.622794
ZWL 355.025874
  • RBGPF

    -0.2800

    67.72

    -0.41%

  • RYCEF

    0.0200

    9.8

    +0.2%

  • CMSD

    -0.1600

    22.67

    -0.71%

  • CMSC

    -0.2400

    22.26

    -1.08%

  • JRI

    -0.2200

    12.82

    -1.72%

  • SCS

    -0.7200

    10.74

    -6.7%

  • BCC

    -7.4400

    94.63

    -7.86%

  • RIO

    -1.4700

    58.43

    -2.52%

  • VOD

    0.2500

    9.37

    +2.67%

  • RELX

    0.4600

    51.44

    +0.89%

  • NGG

    3.6100

    69.39

    +5.2%

  • GSK

    1.3700

    39.01

    +3.51%

  • BCE

    0.8400

    22.66

    +3.71%

  • AZN

    1.7000

    73.92

    +2.3%

  • BP

    -2.4700

    31.34

    -7.88%

  • BTI

    1.6700

    41.92

    +3.98%

Mice trial raises hopes for 'on demand' male contraceptive
Mice trial raises hopes for 'on demand' male contraceptive / Photo: PETER PARKS - AFP/File

Mice trial raises hopes for 'on demand' male contraceptive

If women have the "morning after" pill, could men one day have an "hour before" pill?

Text size:

A new drug candidate renders male mice infertile within an hour and wears off in less than a day, an experimental study said Tuesday, potentially pointing towards a future "on-demand" male contraceptive.

The potential drug, which has not been tested in humans and remains years away from possibly becoming available, joins a growing number of male contraceptives in development.

However there are currently only two options available for men: condoms and vasectomies.

Previous drugs have struggled partly because the bar for side effects is believed to be far higher for men -- because they do not risk getting pregnant -- as well as a lack of interest from the pharmaceutical industry.

"For women, right now all the burden of contraception is on us," Melanie Balbach, a pharmacology researcher at Weill Cornell Medicine in the US, told AFP.

"We want new options," said Balbach, the lead author of the study published in Nature Communications.

The team of researchers targeted an enzyme called soluble adenylyl cyclase, which acts as the "on switch" for sperm, said study co-author Jochen Buck, also of Weill Cornell Medicine.

If the enzyme is switched off, the sperm can no longer move, he said.

Across several different tests, the researchers showed that a compound which blocks the enzyme renders mice sperm immobile in 30 minutes to an hour.

The compound was 100 percent effective in preventing pregnancy within the first two hours, dropping to 91 percent in the first three hours, the study said.

After 24 hours, the mice sperm moved like normal again.

- 'Eye-catching advantage' -

The researchers hope are aiming for a single non-hormonal pill that works in under an hour and lasts six to 12 hours, Buck said.

This would be much different to other options under development, such as a hormonal gel currently going through human trials, which all take weeks or months to start and stop working.

No side effects were noticed in the mice. Previous research has suggested that infertile men who had their soluble adenylyl cyclase enzyme permanently switched off had an increased rate of kidney stones.

Buck said this was the result of their enzyme always being off -- which would not be the case for men taking an on demand pill.

The researchers hope to hold the first trials on humans within three years, with a final product possibly up to eight years away, Buck said.

Susan Walker, an expert in contraception at the UK's Anglia Ruskin University not involved in the research, said she was a "little sceptical" a pill would actually make it to market as so many other efforts have fallen short.

But the "eye-catching advantage" of almost immediate effectiveness offered "the possibility of seeing a sexual partner take a pill," she said.

The consultancy Desire Line is working on forecasting the potential uptake of a range of male contraceptive products, according to its founder Steve Kretschmer.

"Initial estimates indicate in the United States that uptake for an on-demand pill which has quick onset of action and 1-2 days duration of action could be about triple that of Viagra when it was initially launched," he told AFP.

N.Zaugg--NZN